HeartHero Secures Oversubscribed Series A Funding to Advance FDA Submission for Revolutionary AED 'Elliot'

2019Year7Month25Day, VCBeat (WeChat ID:vcbeat) learned that, HeartHeroannouncing the closing of its oversubscribedAround of financing. This funding is forElliotProvides a pathway（Elliotis an industryDisruptionAutomated External Defibrillator (AED））, the defibrillator will be submittedFDA IIIGrade andCEMark CertificationApplication. This roundFinancing has made mass production possible., andPromisingLaunchitsRegardingAEDunique market launch strategy.

HeartHero is honored to partner with Garrett Technologies, a company with over 30 years of expertise in defibrillation. They have successfully designed and manufactured two FDA-approved AEDs. Michael Garrett, CEO of Garrett Technologies, stated, “We are thrilled to participate in this project and collaborate with the HeartHero team. It is also an honor to contribute our knowledge in AED and medical device development to save lives. When cardiac arrest occurs, access to immediately available and easy-to-use AEDs is critical. HeartHero’s Elliot device will provide smaller, simpler on-site AEDs for patients to use when they need life-saving assistance most.”

Following Elliot’s dual recognition as the “Most Innovative Medical Device” by the American College of Emergency Physicians (2018) and the American College of Cardiology (2019), HeartHero has achieved substantial financial gains and is poised to launch Elliot into the global market in 2020. Gary Montague, Founder and CEO of HeartHero, stated, “The oversubscription for HeartHero reflects the shared enthusiasm of both the company and its investors. Elliot is the first life-saving device that will fundamentally reshape conventional perceptions of automated external defibrillators (AEDs) and transform the global response to sudden cardiac arrest (SCA). Our goal has always been to bring an affordably priced device to market, guided by our mission to prioritize lives over profits.”

COPIC, a Series A investor in HeartHero and an industry-leading medical liability insurance company, also adheres to the business philosophy of “lives before profits.” Gerald Zarlengo, CEO of COPIC, believes that HeartHero is leveraging advanced technology to achieve the clear and meaningful goal of saving more lives. This innovation aligns with COPIC’s mission to serve communities and improve healthcare, and has the potential to provide better care for patients experiencing sudden cardiac arrest (SCA).

HeartHero is a medical device startup and the inventor of ultra-portable, affordable, and user-friendly automated external defibrillators (AEDs). HeartHero aims to empower families to help their loved ones live longer, fuller lives.

A revolutionary personal AED device developed by HeartHero, wallet-sized and weighing just over one pound (approximately 1.29 kg), powered by commercially available batteries and operable via a smartphone app.

(Compiled by Tian Shuhang)